Close Menu

Losing the Award

Three grants issued by the California Institute of Regenerative Medicine have been terminated, reports The Scientist. In reviewing the recipients' first year progress reports, CIRM identified underperforming project. The reviewers then contacted the PIs to learn what the difficulties were and then if the grantees' follow-up report didn't show improvement, the grant was terminated. "Termination is a last option," CIRM's Don Gibbons says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.